These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21506625)

  • 1. Hospital costs, length of stay and mortality associated with childhood, adolescent and young adult meningococcal disease in the US.
    Davis KL; Bell TJ; Miller JM; Misurski DA; Bapat B
    Appl Health Econ Health Policy; 2011 May; 9(3):197-207. PubMed ID: 21506625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost impact of complications in meningococcal disease: evidence from a United States managed care population.
    Davis KL; Misurski D; Miller J; Karve S
    Hum Vaccin; 2011 Apr; 7(4):458-65. PubMed ID: 21795848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children.
    Wang B; Haji Ali Afzali H; Marshall H
    Vaccine; 2014 Aug; 32(37):4791-8. PubMed ID: 24998605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
    Brooks R; Woods CW; Benjamin DK; Rosenstein NE
    Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic burden of invasive meningococcal disease: Evidence from a large German claims database.
    Huang L; Heuer OD; Janßen S; Häckl D; Schmedt N
    PLoS One; 2020; 15(1):e0228020. PubMed ID: 31990941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing meningococcal disease in the United States: Hospital case characteristics and costs by age.
    O'Brien JA; Caro JJ; Getsios D
    Value Health; 2006; 9(4):236-43. PubMed ID: 16903993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
    Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and meningococcal serogroup distribution in the United States.
    Hershey JH; Hitchcock W
    Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868
    [No Abstract]   [Full Text] [Related]  

  • 9. Hospital admissions for meningococcal infection in Spain (1997-2005).
    Montero JM; Prieto RG; Alejandre CG; Meca LA; Portugal P; de Miguel AG
    J Infect; 2009 Jan; 58(1):15-20. PubMed ID: 19042024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based analysis of meningococcal disease mortality in the United States: 1990-2002.
    Sharip A; Sorvillo F; Redelings MD; Mascola L; Wise M; Nguyen DM
    Pediatr Infect Dis J; 2006 Mar; 25(3):191-4. PubMed ID: 16511378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines.
    Poland GA
    Clin Infect Dis; 2010 Mar; 50 Suppl 2():S45-53. PubMed ID: 20144016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura.
    Danese MD; Lindquist K; Gleeson M; Deuson R; Mikhael J
    Am J Hematol; 2009 Oct; 84(10):631-5. PubMed ID: 19705429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of pediatric traumatic brain injury and associated hospital resource utilization in the United States.
    Schneier AJ; Shields BJ; Hostetler SG; Xiang H; Smith GA
    Pediatrics; 2006 Aug; 118(2):483-92. PubMed ID: 16882799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with hospital length of stay and hospital charges of motor vehicle crash related hospitalizations among children in the United States.
    Gardner R; Smith GA; Chany AM; Fernandez SA; McKenzie LB
    Arch Pediatr Adolesc Med; 2007 Sep; 161(9):889-95. PubMed ID: 17768290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hospital admissions for meningococcal infections in Madrid, Spain (1997-2005)].
    Gil Prieto R; Alvarez Morán JL; Portugal P; San Román Montero J; Alvaro A; Rivero Cuadrado A
    Med Clin (Barc); 2010 Apr; 134(12):534-9. PubMed ID: 20036397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of meningococcal disease associated with genomic bacterial load.
    Darton T; Guiver M; Naylor S; Jack DL; Kaczmarski EB; Borrow R; Read RC
    Clin Infect Dis; 2009 Mar; 48(5):587-94. PubMed ID: 19191644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
    Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
    [No Abstract]   [Full Text] [Related]  

  • 18. Invasive pediatric Neisseria meningitidis infections.
    Tuan PL; Li WC; Huang YC; Chiu CH; Lin TY
    J Microbiol Immunol Infect; 2009 Oct; 42(5):427-32. PubMed ID: 20182673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on meningococcal disease mortality in the United States since 2002.
    Kim GY; Sorvillo F; Kuo T
    Pediatr Infect Dis J; 2010 Jul; 29(7):681. PubMed ID: 20574406
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for invasive meningococcal disease in southern Queensland, 2000-2001.
    McCall BJ; Neill AS; Young MM
    Intern Med J; 2004 Aug; 34(8):464-8. PubMed ID: 15317544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.